Emerging Three-Dimensional Hepatic Models in Relation to Traditional Two-Dimensional In Vitro Assays for Evaluating Drug Metabolism and Hepatoxicity-Reference-Cited by-同舟云学术

Emerging Three-Dimensional Hepatic Models in Relation to Traditional Two-Dimensional In Vitro Assays for Evaluating Drug Metabolism and Hepatoxicity

Published:2020-12 Issue: Volume:8 Page:100060
ISSN:2590-0986
Container-title:Medicine in Drug Discovery
language:en
Short-container-title:Medicine in Drug Discovery

Author:

Milner Erin,Ainsworth Michael,McDonough Matthew,Stevens Benjamin,Buehrer Johannah,Delzell Richard,Wilson Cameron,Barnhill Jason

Funder

United States Military Academy

Publisher

Elsevier BV

Subject

Pharmacology (medical),Drug Discovery,Pharmacology

Reference69 articles.

1. Drug-Induced Liver Injury: Premarketing Clinical Evaluation;U.S. Department of Health and Human Services,2009

2. Hepatic and Intestinal Drug Transporters: Prediction of Pharmacokinetics Effects Caused by Drug-Drug Interactions and Genetic Polymorphisms;Yoshida;Annu Rev Pharmacol Toxicol,2013

3. Safety Testing of Drug Metabolites: Guidance for Industry;U.S. Department of Health and Human Services,2020

4. Characterization of hepatocyte-based in vitro systems for reliable toxicity testing;Vinken;Arch Toxicol,2018

5. Competency of different cell models to predict human heparotoxic drugs;Gómez-Lechón;Expert Opin Drug Metab Toxicol,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coculture model of a liver sinusoidal endothelial cell barrier and HepG2/C3a spheroids-on-chip in an advanced fluidic platform;Journal of Bioscience and Bioengineering;2024-01

2. A review of challenges and prospects of 3D cell-based culture models used for studying drug induced liver injury during early phases of drug development;Human & Experimental Toxicology;2023-03-06

3. In vitro functional models for human liver diseases and drug screening: beyond animal testing;Biomaterials Science;2023

4. Development of a high-throughput micropatterned agarose scaffold for consistent and reproducible hPSC-derived liver organoids;Biofabrication;2022-10-28

5. In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation;Drug Metabolism Reviews;2022-04-03